Cardiopathy No Basis for Choosing Anticoagulation in ESUS

Clinicians shouldn't expect apixaban to offer benefit over aspirin in patients with embolic stroke of undetermined source simply because they have atrial cardiopathy, ARCADIA investigators conclude.
Medscape Medical News

source https://www.medscape.com/viewarticle/992525?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?